Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-20-032015
Filing Date
2020-12-18
Accepted
2020-12-18 17:19:32
Documents
2
Period of Report
2020-12-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 2443
2 POWER OF ATTORNEY (PUBLIC): doc1.txt EX-24 5580
  Complete submission text file 0001127602-20-032015.txt   9567
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Issuer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ALKERMES 852 WINTER STREET WALTHAM MA 02451
Business Address
Daglio David Angelo Jr. (Reporting) CIK: 0001837109 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35299 | Film No.: 201401545